Trademarkia Logo

Australia

AU$
REPLIVEL
Removed - Not renewed: Renewal fee not paid

Last updated on 18 Jan 2018

Owner Info

Sunesis Pharmaceuticals, Inc., a Delaware corporation

341 Oyster Point Boulevard,

South San Francisco,, UNITED STATES OF AMERICA

Serial Number

1182945 filed on 19 Jun 2007

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

REPLIVEL

Classification Information


Class [005]
Pharmaceutical preparations, including pharmaceutical preparations for the treatment of tumours and cancer

Mark Details


Serial Number

1182945

Registered On

19 Jun 2007

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

22 Dec 2006

Mark Type

US

Legal History


Show more

Status DateAction Taken
18th Jan 2018Trade Marks Removed from Register Published
9th Jan 2018Remove Trade Mark Non-Payment Renewal
3rd Jul 2017Registration Status Change
18th Apr 2017Renewal Reminder correspondence sent
20th Jun 2016Registration Status Change
22nd Nov 2007IP Right Registration Published
5th Nov 2007Application Status
5th Nov 2007Register Trade Mark
26th Oct 2007Registration fee (1 class)
3rd Aug 2007General correspondence Acceptance